This year’s Texas Academic Performance Report for Waco Independent School District does not carry a letter grade due to pending litigation, but still signals areas for improvement, such as in ...

Whales with a lot of money to spend have taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 9 trades. If we consider the specifics of each ...

Not only did AbbVie’s Skyrizi claim first place in the full-year ranking with nearly $377 million spent on 20 separate ads for the drug, according to iSpot.TV’s analysis, but, with two other ...

ABBV-787 is under clinical development by AbbVie and currently in Phase I for Refractory Acute Myeloid Leukemia. According to GlobalData, Phase I drugs for Refractory Acute Myeloid Leukemia have a 68% ...

Astound offers some of the most affordable broadband in Waco with a plan that starts at 300 megabits per second at just $20 a month, including equipment. Need speed? AT&T Fiber offers symmetrical ...

WACO, Texas (KWTX) - TxDOT announced that their crews in the Waco District will be preparing roadways on Sunday, January 19. TxDOT says this step is “to begin early brine application on State ...

AbbVie (NYSE:ABBV) has managed to keep its market share for its bestselling arthritis therapy, Humira, above 70%, generic drugmaker Samsung Bioepis said in a new report on Thursday as the ...

Once Humira biosimilars entered the US markets in 2023, drug revenues declined by 32% for AbbVie. Image credit: Skorzewiak / Shutterstock AbbVie executives say the company’s immunology drugs Skyrizi ...

AbbVie closed out the year on a high note as its blockbuster biologic Skyrizi once again claimed the top spot in 2024’s final monthly ranking of the biggest TV ad spenders in biopharma.

AbbVie and Gilead are going back to their roots and leaning on their established areas of expertise to set themselves up for sustainable success in 2025. With explosive deals out of the way, news from ...

AbbVie leaders are “disappointed” with poor results from a schizophrenia drug the company acquired last year that led to a $3.5 billion impairment charge, but they say they aren’t completely ...

AbbVie will receive royalties on net sales within Greater China. Credit: © AbbVie Inc. All rights reserved. AbbVie and Simcere Zaiming have announced an option-to ...